object
assess
whether
glycoprotein
agp
detect
membran
felin
circul
leucocyt
design
presenc
agp
circul
leucocyt
investig
clinic
healthi
cat
cat
differ
diseas
group
felin
coronaviru
fcov
posit
cat
compris
cat
felin
infecti
periton
fip
cat
affect
fip
seroposit
fcov
includ
studi
serum
concentr
agp
increas
fcov
infect
procedur
flow
cytometri
use
antifelin
agp
antibodi
serum
protein
electrophoresi
routin
haematolog
measur
serum
agp
concentr
perform
use
blood
sampl
healthi
cat
fcovseroposit
cat
fip
diseas
fcovseroposit
proport
cat
agpposit
leucocyt
differ
group
eg
control
vs
sick
fip
vs
diseas
etc
cat
differ
intens
inflammatori
respons
compar
use
chisquar
test
result
agpposit
leucocyt
found
cat
compar
control
proport
patient
posit
granulocyt
monocyt
higher
among
sick
cat
especi
cat
diseas
fip
cat
high
serum
agp
concentr
cat
leucocytosi
fcovseroposit
conclus
agpposit
leucocyt
found
felin
blood
especi
inflamm
convers
associ
agpposit
leucocyt
fip
found
studi
need
elucid
mechan
respons
find
diagnost
role
cat
inflamm
cat
fip
includ
fcovposit
group
intralesion
fcov
detect
necropsi
six
cat
also
test
immunofluoresc
five
antibodi
titr
higher
posit
threshold
laboratori
agp
glycoprotein
fcov
felin
coronaviru
fip
felin
infecti
periton
fiv
felin
immunodefici
viru
small
anim
small
anim
glycoprotein
agp
major
felin
acutephas
protein
app
high
affin
small
hydrophob
molecul
immunomodulatori
properti
human
rate
agp
sialyl
seem
protect
viral
infect
serum
concentr
felin
agp
increas
sever
pathophysiolog
condit
use
biomark
inflamm
mani
inflammatoryinfecti
diseas
togeth
app
serum
amyloid
promin
increas
record
cat
felin
infecti
periton
fip
lethal
diseas
caus
felin
coronaviru
fcov
agp
hyposialyl
huge
increas
agp
consid
power
biomark
fip
especi
pretest
probabl
diseas
high
transient
increas
serum
concentr
rate
sialyl
agp
also
record
clinic
healthi
cat
live
fcovendem
environ
human
bovin
leucocyt
express
messeng
rna
mrna
code
agp
agp
membran
intracellular
granul
report
blood
tissu
signific
debat
presenc
agp
leucocyt
cat
never
investig
aim
studi
investig
flow
cytometri
presenc
agp
circul
leucocyt
healthi
fcovseroposit
fcovseroneg
cat
cat
affect
differ
diseas
includ
fip
inform
would
increas
knowledg
agp
possibl
diagnost
role
presenc
agpposit
leucocyt
clearli
associ
specif
patholog
condit
detect
agpbear
leucocyt
would
addit
ancillari
test
support
clinic
diagnosi
inflammatori
diseas
studi
carri
use
blood
sampl
collect
group
clinic
healthi
cat
group
cat
clinic
sign
laboratori
chang
consist
fip
n
inflamm
n
intestin
ocular
respiratori
abscess
trauma
n
lymphoma
n
felin
immunodefici
viru
fiv
infect
n
cat
clinic
sign
receiv
treatment
includ
studi
cat
group
accord
physic
examin
result
diagnost
imag
biochem
haematolog
serolog
test
perform
refer
veterinarian
well
followup
result
includ
postmortem
examin
case
death
cat
classifi
clinic
healthi
clinic
sign
laboratori
abnorm
among
sick
cat
diagnosi
fip
base
necropsi
histolog
immunohistochemistri
fcov
antigen
cat
die
clinic
suspicion
fip
confirm
immunohistochemistri
includ
studi
diagnosi
fip
exclud
necropsi
result
inconsist
fip
includ
neg
immunohistochemistri
fcov
improv
clinic
condit
appropri
therapi
lack
sign
consist
fip
followup
group
includ
cat
either
fip
seroposit
fcov
hereaft
term
seroposit
use
specif
indic
cat
without
fip
circul
antifcov
antibodi
term
fcovposit
use
gener
indic
seroposit
cat
cat
fip
cat
privat
own
sampl
routin
diagnost
screen
inform
consent
given
owner
blood
collect
jugular
vein
divid
two
aliquot
one
aliquot
put
plain
tube
obtain
serum
centrifug
frozen
analys
within
month
aliquot
place
edtaco
tube
haematolog
flow
cytometri
perform
within
h
sampl
complet
cell
blood
count
blood
sampl
perform
use
imped
counter
hemat
seac
calenzano
firenz
itali
differenti
leucocyt
count
determin
microscop
blood
smear
stain
may
haematolog
perform
remain
sampl
agp
measur
singl
radial
immunodiffus
srid
flow
cytometri
cellulos
acet
electrophoresi
sampl
perform
use
autom
equip
genio
interlab
srl
rome
itali
electrophoresi
perform
remain
sampl
agp
measur
srid
flow
cytometri
strip
run
buffer
solut
min
v
stain
ponceau
red
destain
diaphanis
solut
provid
manufactur
genio
interlab
srl
electropherogram
gener
densitomet
includ
instrument
agp
measur
use
srid
kit
tridelta
maynooth
kildar
ireland
follow
ml
sampl
standard
solut
contain
mgml
mgml
agp
respect
put
well
multiwel
srid
plate
incub
h
room
temperatur
diamet
precipit
ring
measur
valu
obtain
standard
solut
use
design
refer
curv
valu
case
sampl
plot
extrapol
agp
concentr
antifcov
serolog
perform
cat
cat
fip
test
includ
fcovposit
group
intralesion
viru
immunohistochem
detect
necropsi
use
indirect
immunofluoresc
test
perform
multiwel
slide
produc
univers
zurich
briefli
well
coat
cell
half
infect
swine
transmiss
gastroenter
viru
serolog
crossreact
fcov
slide
fix
aceton
dri
frozen
store
use
serum
sampl
dilut
basi
first
dilut
provid
neg
result
ml
dilut
appli
wellsaft
incub
moist
chamber
slide
wash
three
time
phosphatebuff
salin
pb
dri
next
ml
fluorescein
fitc
conjug
rabbitanticat
immunoglobulin
nordic
immunolog
laboratori
tilburg
netherland
ad
well
incub
min
slide
wash
dri
coverslip
pb
kaiser
glycerin
vv
examin
use
fluoresc
microscop
dilut
show
distinct
fluoresc
signal
approxim
half
cell
classifi
posit
anticoagul
blood
ml
incub
min
room
temperatur
ml
lysi
solut
contain
ammonium
chlorid
lyse
red
blood
cell
tube
centrifug
min
pellet
wash
ml
pb
centrifug
wash
repeat
twice
pellet
resuspend
ml
rpmi
contain
fetal
calf
serum
fc
sodium
azid
cell
count
dilut
cellsml
rpmi
contain
fc
sodium
azid
next
ml
polyclon
antifelin
agp
antibodi
dilut
rais
sheep
kindli
provid
professor
david
eckersal
univers
glasgow
uk
ad
cell
suspens
neg
control
ml
cell
suspens
ad
ml
sheep
normal
serum
dilut
incub
min
dark
cell
wash
twice
rpmifcssodium
azid
centrifug
min
secondari
antibodi
ml
fitcconjug
donkey
antisheep
igg
serotec
oxford
uk
use
order
identifi
possibl
nonspecif
bind
secondari
antibodi
ml
cell
suspens
incub
secondari
antibodi
alon
leucocyt
subpopul
identifi
monoclon
antibodi
specif
follow
antigen
cell
clone
vmrd
pullmann
usa
ml
express
mani
cell
line
highest
express
neutrophil
clone
serotec
ml
monocyt
clone
peconjug
serotec
ml
secondari
antibodi
unconjug
primari
antibodi
ml
fitcconjug
antimous
igg
serotec
use
incub
cell
wash
resuspend
pb
acquir
facscalibur
flow
cytomet
equip
cell
quest
softwar
becton
dickinson
san
jose
ca
usa
data
minimum
event
collect
leucocyt
subpopul
identifi
backgat
techniqu
cell
display
fluoresc
fluoresc
versu
side
scatter
ssc
gate
place
around
posit
cell
lineagerestrict
cell
marker
posit
popul
identifi
forward
scatter
fsc
versu
ssc
plot
second
gate
drawn
second
gate
scatterplot
use
display
cell
agp
histogram
statist
analys
perform
excel
spreadsheet
analyseit
set
macroinstruct
analyseit
softwar
leed
uk
cell
popul
neutrophil
lymphocyt
monocyt
pearson
chisquar
test
use
compar
proport
posit
cat
comparison
result
consid
signific
p
clinic
healthi
cat
occasion
laboratori
abnorm
tabl
case
howev
chang
minim
moder
except
evid
lymphocytosi
found
two
cat
lymphocytesml
refer
interv
ml
nineteen
cat
group
seroposit
fcov
titr
cat
fip
affect
wet
form
laboratori
chang
consist
fip
lymphopenia
increas
gglobulin
except
two
cat
agp
valu
within
refer
rang
mgml
respect
five
six
cat
fip
serolog
perform
fcovseroposit
titr
statist
comparison
cat
fip
includ
fcovposit
group
intralesion
fcov
detect
necropsi
cat
inflammatori
process
fip
mild
neutrophilia
neutropenia
moder
sever
lymphopenia
increas
concentr
gglobulin
increas
agp
mgml
three
cat
also
seroposit
fcov
titr
lymphocytosi
lymphopenia
found
cat
trauma
one
cat
lymphocytosi
also
monocytosi
increas
agp
concentr
fcovseroposit
titr
one
lymphopen
cat
also
increas
agp
concentr
mgml
cat
lymphoma
lymphocytosi
increas
agp
concentr
mgml
fcovseroposit
titr
cat
fiv
increas
agp
mgml
concentr
fcovseroposit
titr
approxim
cat
agp
detect
flow
cytometri
least
one
leucocyt
popul
specif
agp
frequent
detect
granulocyt
lymphocyt
monocyt
present
posit
signal
clearli
detect
although
weak
case
figur
less
clinic
healthi
cat
agpposit
leucocyt
tabl
percentag
cat
agpposit
neutrophil
higher
sick
healthi
cat
percentag
cat
fip
agpposit
neutrophil
significantli
higher
p
control
contrast
percentag
cat
posit
neutrophil
monocyt
significantli
higher
cat
diseas
fip
control
signific
differ
proport
cat
agpposit
leucocyt
found
fcovposit
fcovneg
cat
tabl
among
fcovposit
cat
howev
proport
cat
express
agp
neutrophil
higher
sick
cat
affect
either
fip
diseas
control
percentag
cat
agpposit
tabl
proport
cat
agpposit
neutrophil
monocyt
significantli
higher
among
cat
increas
agp
respect
group
normal
agp
respect
signific
differ
proport
cat
agpposit
leucocyt
found
cat
normal
increas
leucocyt
count
tabl
human
protein
compos
agp
hydrophob
transmembran
peptid
identifi
thought
product
andor
releas
protein
activ
leucocyt
could
respons
increas
concentr
circul
agp
record
serum
inflamm
neoplasia
releas
intracytoplasm
agp
human
bovin
granulocyt
also
report
contrast
vitro
studi
demonstr
uptak
solubl
agp
cell
neutrophil
especi
monocyt
macrophag
agpbind
depend
dose
glycosyl
pattern
agp
thu
postul
excess
agp
serum
clear
leucocyt
via
endocytosi
possibl
occur
myeloid
neoplasm
bind
membran
receptor
ligand
sialic
acid
call
immunoglobulinlik
lectin
result
present
studi
demonstr
felin
agp
surfac
circul
leucocyt
detect
flow
cytometri
although
less
clinic
healthi
cat
posit
cell
blood
antibodi
use
studi
recognis
purifi
felin
agp
western
blot
agp
expos
tissu
cell
immunohistochemistri
crossreact
protein
felin
serum
effus
high
frequenc
neg
result
like
reflect
low
number
cat
actual
expos
agp
leucocyt
rather
poor
specif
antibodi
amount
agp
circul
leucocyt
probabl
low
detect
flow
cytometri
preliminari
test
base
immunocytochemistri
data
shown
accur
method
investig
type
agpposit
cell
would
doublestain
techniqu
use
antiagp
antibodi
antibodi
leucocyt
marker
unfortun
antifelin
agp
antibodi
antileucocyt
antibodi
use
present
studi
conjug
thu
indirect
doublestain
techniqu
could
perform
increas
risk
lose
cell
wash
procedur
high
background
fluoresc
nonspecif
bind
base
result
possibl
understand
clinic
healthi
cat
agpposit
leucocyt
blood
case
cat
slight
laboratori
chang
interpret
either
normal
individu
variabl
compar
refer
interv
effect
transient
pathophysiolog
process
fear
lymphocytosi
stress
neutrophilia
andor
lymphopenia
therefor
exclud
stress
fear
associ
presenc
agpposit
leucocyt
agpposit
neutrophil
andor
monocyt
detect
cat
increas
serum
agp
concentr
leucocytosi
suggest
direct
relationship
inflamm
rather
high
number
cell
potenti
abl
bind
agp
hypothesi
support
fact
sick
cat
heterogen
term
diseas
type
inflammatori
chang
increas
agp
andor
globulin
fraction
moreov
inflammatori
condit
includ
studi
except
fiv
lymphoma
acut
clinic
cours
activ
acutephas
reaction
seem
key
event
associ
presenc
agpposit
leucocyt
especi
neutrophil
monocyt
involv
innat
immun
studi
focu
mechan
respons
presenc
agp
leucocyt
membran
test
focu
understand
whether
presenc
agp
leucocyt
sick
cat
depend
cell
activ
postul
human
bovin
increas
serum
agp
perform
studi
preliminari
polymeras
chain
reaction
pcr
test
fail
amplifi
mrna
code
agp
leucocyt
data
shown
neg
result
howev
exclud
possibl
agp
synthesis
myeloid
precursor
store
neutrophil
granul
human
releas
inflammatori
stimuli
latter
hypothesi
howev
test
present
studi
design
sampl
collect
healthi
cat
cat
spontan
diseas
bone
marrow
aspir
cat
would
repres
unnecessarili
pain
stress
procedur
howev
aspect
merit
investig
anim
chronic
inflamm
eg
noneffus
fip
characteris
stronger
activ
immun
system
monitor
followup
assess
whether
cours
diseas
andor
respons
therapi
associ
chang
number
agpposit
leucocyt
final
seem
fcov
infect
influenc
presenc
agp
leucocyt
studi
fcov
statu
estim
serolog
correl
viral
burden
determin
pcr
test
faec
suggest
presenc
activ
fcovhost
interact
potenti
abl
activ
acutephas
reaction
fcovseroposit
cat
found
among
clinic
healthi
sick
cat
previous
report
proport
cat
agpposit
leucocyt
significantli
differ
accord
fcov
statu
serum
agp
concentr
agp
sialyl
leucocyt
respons
clinic
healthi
fcovposit
cat
differ
cat
fip
find
differ
number
cat
agpposit
leucocyt
would
support
hypothesi
agpbear
leucocyt
might
influenc
fcovhost
interact
potenti
p
vs
clinic
healthi
cat
p
vs
clinic
healthi
fcovposit
cat
see
tabl
agp
glycoprotein
fcov
felin
coronaviru
fip
felin
infecti
periton
immunomodulatori
properti
agp
howev
hypothesi
support
result
studi
proport
cat
agp
leucocyt
increas
cat
fip
diseas
fip
possibl
role
agp
resist
suscept
fip
hypothesis
previou
studi
involv
agpbear
leucocyt
conclus
first
studi
document
presenc
agp
membran
circul
felin
leucocyt
specif
studi
demonstr
agp
occasion
found
leucocyt
clinic
healthi
cat
proport
cat
agpposit
neutrophil
monocyt
increas
among
sick
anim
like
associ
presenc
inflamm
rather
presenc
fcov
leucocytosi
clinic
perspect
result
suggest
presenc
agpposit
leucocyt
could
consid
marker
inflamm
marker
inflamm
includ
app
concentr
serum
current
avail
routin
practic
test
access
less
expens
flow
cytometri
nevertheless
measur
serum
marker
inflamm
provid
equivoc
result
detect
agpexpress
leucocyt
flow
cytometri
could
ancillari
test
support
clinic
suspicion
inflamm
studi
focu
mechan
respons
presenc
agp
leucocyt
membran
result
encourag
futur
studi
mechan
event
induc
increas
presenc
agpposit
leucocyt
cat
inflamm
addit
studi
evalu
diagnost
andor
prognost
role
presenc
agpposit
leucocyt
